These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16612874)

  • 1. Selected clinical trials in breast cancer.
    Clin Breast Cancer; 2006 Feb; 6(6):540-1. PubMed ID: 16612874
    [No Abstract]   [Full Text] [Related]  

  • 2. Current and future trends in the multidisciplinary approach for high-risk breast cancer. The experience of the Milan Cancer Institute.
    Bonadonna G
    Eur J Cancer; 1996 Feb; 32A(2):209-14. PubMed ID: 8664029
    [No Abstract]   [Full Text] [Related]  

  • 3. Issues in the chemotherapy of breast cancer.
    de Graaf H; Willemse PH; de Vries EG; Mulder NH
    Neth J Med; 1998 Sep; 53(3):97-108. PubMed ID: 9803140
    [No Abstract]   [Full Text] [Related]  

  • 4. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: the example of clinical studies].
    Sdrobolini A
    Suppl Tumori; 2004; 3(4):S77-8. PubMed ID: 15206220
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant therapy for patients with node negative breast cancer.
    Amoroso D; Boccardo F
    Tumori; 2000; 86(5 Suppl 1):S17-21. PubMed ID: 11195288
    [No Abstract]   [Full Text] [Related]  

  • 6. Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity.
    Coveler AL; Goodell V; Webster DJ; Salazar LG; Fintak PA; Childs JS; Higgins DM; Disis ML
    Breast Cancer Res Treat; 2009 Jan; 113(1):95-100. PubMed ID: 18236151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metastatic cancer of the breast. Study of intensive induction of remission chemotherapy. Controlled clinical trial].
    Jouve M; Palangie T; Dorval T; Garcia-Giral E; Asselain B; Coutant M; Pouillart P
    Bull Cancer; 1986; 73(6):683-4. PubMed ID: 3552083
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
    Smith GA; Henderson IC
    Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose chemotherapy for breast cancer.
    Antman KH; Heitjan DF; Hortobagyi GN
    JAMA; 1999 Nov; 282(18):1701-3. PubMed ID: 10568629
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adjuvant therapies in breast carcinoma].
    Joss R; Brunner K
    Schweiz Rundsch Med Prax; 1991 Mar; 80(11):247-54. PubMed ID: 2024099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.
    Albain KS
    J Natl Cancer Inst; 2004 Dec; 96(24):1801-4. PubMed ID: 15601631
    [No Abstract]   [Full Text] [Related]  

  • 12. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
    Tamura K
    Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
    [No Abstract]   [Full Text] [Related]  

  • 13. Hexamethylmelamine use in the treatment of metastatic breast cancer.
    Henderson IC; Shapiro CL
    Cancer Treat Rev; 1991 Mar; 18 Suppl A():91-8. PubMed ID: 1904313
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy for metastatic breast cancer.
    Nabholtz JM; Reese DM; Lindsay MA; Riva A
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):169-80. PubMed ID: 12113239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The primary use of chemotherapy for operable breast cancer: does systemic therapy make surgery superfluous?
    Rudenstam CM
    Recent Results Cancer Res; 1996; 140():177-88. PubMed ID: 8787061
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant systemic therapy: the issues of timing and sequence.
    Castiglione-Gertsch M; Gelber RD; Goldhirsch A
    Recent Results Cancer Res; 1996; 140():201-13. PubMed ID: 8787063
    [No Abstract]   [Full Text] [Related]  

  • 17. Lapatinib: new drug. For some women with metastatic breast cancer.
    Prescrire Int; 2009 Feb; 18(99):9. PubMed ID: 19382400
    [No Abstract]   [Full Text] [Related]  

  • 18. Future developments in adjuvant systemic therapy for high-risk breast cancer.
    Bonadonna G
    Recent Results Cancer Res; 1996; 140():227-34. PubMed ID: 8787065
    [No Abstract]   [Full Text] [Related]  

  • 19. [New strategies for therapy of breast cancer. San Antonio Breast Cancer Symposium, 2002].
    Loibl S; von Minckwitz G; Kaufmann M
    Zentralbl Gynakol; 2002 Oct; 124(10):451-3. PubMed ID: 12712385
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
    Du XL
    J Natl Cancer Inst; 2003 May; 95(9):683; author reply 684-5. PubMed ID: 12734321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.